Name: UMIN ID:
Unique ID issued by UMIN | UMIN000025936 |
---|---|
Receipt number | R000029819 |
Scientific Title | Japanese AntibaCterial drug maNagemEnt for cardiac Sarcoidosis Trial |
Date of disclosure of the study information | 2017/02/20 |
Last modified on | 2023/08/07 14:02:47 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/01/31 23:02:04 | ||
2 | Update | 2017/02/01 09:19:03 | Interventions/Control_1 Key exclusion criteria |
|
3 | Update | 2017/02/01 09:33:33 | Last name of contact person Last name of contact person |
|
4 | Update | 2017/02/01 10:12:35 | Name of person sending information Name of person sending information Institute Institute Organization1 Email1 |
|
5 | Update | 2017/02/02 16:39:02 | Name of person sending information Name of person sending information Division name Division name Name of primary person or sponsor Organization Organization Organization Category of Funding Organization Date of disclosure of the study information |
|
6 | Update | 2017/02/02 16:39:55 | Division name |
|
7 | Update | 2018/08/08 10:37:42 | Recruitment status |
|
8 | Update | 2018/08/08 10:40:18 | Recruitment status |
|
9 | Update | 2018/08/08 10:51:39 | Name of person sending information Name of person sending information Division name Division name |
|
10 | Update | 2019/02/04 13:12:06 | Anticipated trial start date |
|
11 | Update | 2019/08/05 10:14:36 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address TEL Last name of contact person Last name of contact person Zip code Address Address TEL Address Address TEL Address1 Tel1 Organization Organization Address Address Tel |
|
12 | Update | 2021/02/04 12:57:22 | Date of IRB Last follow-up date |
|
13 | Update | 2021/08/05 10:00:35 | Email |
|
14 | Update | 2022/03/25 13:19:00 | Recruitment status |
|
15 | Update | 2022/08/08 08:46:05 | Date of closure to data entry |
|
16 | Update | 2023/02/09 12:08:06 | Number of participants that the trial has enrolled Results Results Results date posted Results Delayed Results Delay Reason Results Delay Reason Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
17 | Update | 2023/08/07 14:02:47 | Email1 |